Related Experiment Video
Updated: Aug 5, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Autologous stem cell transplantation for pediatric rheumatic diseases
K S Barron1, C Wallace, Woolfrey CEA
1Division of Intramural Research, National Institute Allergy and Infectious Diseases, and the Office of Rare Diseases, National Institutes of Health, Bethesda, Maryland 20892-1356, USA. Kbarron@nih.gov
Abstract:
The National Institute of Allergy and Infectious Disease, National Institutes of Health, convened a workshop entitled The Next Step: Protocol Development for Autologous Stem Cell Transplantation for Pediatric Rheumatic Disease, June 2000, co-chaired by Drs. Karyl Barron and Carol Wallace. The goal of the workshop was to focus on the scientific rationale for stem cell transplantation therapy in the pediatric diseases, unique aspects of this therapy in the pediatric rheumatic diseases, transplantation issues and options, regulatory issues, and development of a DNA repository for these diseases.
Related Concept Videos
Adult Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

